07 April 2021 | NewsUpcoming webinar: COVID-19 vaccine uptake and acceptanceRead the full article
NCIRS has partnered with WHO to provide direct support to the NITAG of Timor-Leste. This partnership is funded by Gavi, the Vaccine Alliance, from 2019 to 2024, and forms part of Gavi’s post-transition plan for Timor-Leste as the country proceeds towards achieving a self-sufficient and financially sustainable national vaccination program.
NITAGs are multidisciplinary groups of national experts responsible for providing independent, evidence-informed advice to policy makers and program managers on policy issues related to immunisation and vaccines. More information on the Global NITAG Network is available here. Established in November 2015, the Timor-Leste NITAG advises the Ministry of Health on the protection of the Timorese people from VPDs through immunisation.
NCIRS joins other key WHO partners that provide direct support to NITAGs globally, including the US Centers for Disease Control and Prevention, the ProVac Initiative and the Supporting Independent Immunization and Vaccine Advisory Committees (SIVAC) Initiative.
NCIRS support to NITAG T-L mission 29–31 May 2019
An NCIRS delegation visited Dili, Timor-Leste, from 29 to 31 May 2019, to attend a National Immunization Technical Advisory Group Timor-Leste (NITAG-TL) meeting. This visit also provided an opportunity to meet with WHO, the NITAG-TL Chair and the Ministry of Health to discuss how NCIRS could support the NITAG-TL in their continued growth and contribution to immunisation in Timor-Leste.
NITAG-TL visit to NCIRS, 2–5 September 2019
Dr Solange Fernandes, the NITAG-TL Secretariat, visited NCIRS from 2 to 5 September 2019. Dr Fernandes completed the NCIRS Vaccines in Public Health workshop at The University of Sydney, and toured NCIRS and The Children’s Hospital at Westmead. Dr Solange’s visit also provided an opportunity for NCIRS to learn more about the NITAG-TL, and plan for future collaborative work.
NCIRS support to NITAG T-L mission 25–26 September 2019
An NCIRS delegation visited Dili, Timor-Leste, from 25 to 26 September 2019. This trip marked the official launch of the recently formalised five–year technical twinning partnership among NCIRS, WHO and the NITAG-TL, which is funded by the Gavi Alliance. NCIRS delivered an Evidence Based Decision Making Workshop to the NITAG-TL members, participants from the Ministry of Health, UNICEF and other implementation partners.
NCIRS support to NITAG T-L mission 4–8 February 2020
An NCIRS delegation visited Dili, Timor-Leste, from 5 to 8 February 2020. The delegation was joined by Professor Michael Gold, Paediatric Allergist and Immunologist from the University of Adelaide, global adverse events following immunisation (AEFI) expert and long-time NCIRS collaborator. Together, they delivered an AEFI Workshop: Strengthening surveillance and assessment of causality of AEFIs in Timor-Leste to the NITAG-TL members, participants from the Ministry of Health, UNICEF and other implementation partners. The team also toured the Ministry of Health and the National Hospital.
NCIRS, Kids Research, Sydney Children’s Hospitals Network, Cnr Hawkesbury Rd & Hainsworth St, Westmead Locked Bag 4001, Westmead NSW 2145 Tel (612) 9845 1433 | Fax (612) 9845 1418 | ABN 53 188 579 090
We acknowledge that the National Centre for Immunisation Research and Surveillance (NCIRS) is on the land of the traditional owners the Aboriginal and Torres Strait Islander peoples, the First Australians, and recognise their culture, history, diversity and their deep connection to the land. Together, through research and partnership, we aim to move to a place of equity for all. NCIRS also acknowledges and pays respect to other Aboriginal and Torres Strait Islander nations from which our research, staff and community are drawn.
Copyright © 2021 NCIRS. All rights reserved
Our website meets the criteria for credibility and content as defined by the Global Advisory Committee on Vaccine Safety.
Stay updated with the latest from NCIRS